Medical expert of the article
New publications
Preparations
Rabeprazole-health
Last reviewed: 03.07.2025

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Rabeprazole-health is a pharmaceutical product used to treat diseases of the stomach and digestive organs. Let's consider the main indications for its use, dosage and other nuances of use.
Rabeprazole-Zdorovye belongs to the pharmacotherapeutic group of drugs for the treatment of diseases associated with acidity disorders. The chemical and international name of the drug is Rabeprazolum, the manufacturer is the pharmaceutical company "Zdorovye", Ukraine.
Indications Rabeprazole-health
Rabeprazole-health is based on the mechanism of action of its components. The product is effective in the treatment and prevention of:
- Peptic ulcer of the duodenum (in the acute stage)
- Zollinger-Ellison syndrome
- Gastric ulcer (benign)
- Gastroesophageal reflux disease (erosive, ulcerative)
- Symptomatic therapy for moderate to very severe GERD
- Eradication of Helicobacter pylori in combination with active antibacterial drugs.
Before starting the use, the patient must undergo an examination to exclude the possibility of malignant lesions of the stomach. The drug is prescribed with special caution to patients with severe renal and hepatic dysfunction. If the tablets cause drowsiness, then in order to undergo a full course of treatment, it is necessary to abandon activities that require increased concentration.
Release form
Release form - tablets No. 10 with a dosage of 10 and 20 mg. The tablets are biconvex, covered with an enteric coating of brown-red (10 mg) or brown-yellow (20 mg).
One tablet contains the active ingredient - sodium rabeprazole and excipients (mannitol, magnesium stearate, titanium dioxide, mannitol and others).
[ 11 ]
Pharmacodynamics
Pharmacodynamics Rabeprazole-health indicates its antisecretory properties. The drug belongs to antiulcer proton pump inhibitors. The active substance gradually accumulates in the acidic environment of the cells of the gastric mucosa and passes into the active form - sulfenamide. The active metabolite inhibits H +, K + - ATPase, blocks the secretion of hydrochloric acid due to the cessation of the release of hydrogen ions into the gastric cavity.
It has bactericidal properties against Helicobacter pylori and accelerates the anti-Helicobacter activity of other antibiotics. A dose of 20 mg leads to inhibition of gastric secretion within 60 minutes and reaches its maximum after 3-4 hours. Inhibition of basal and stimulated secretion lasts for 48 hours. A stable antisecretory effect occurs 72 hours after the start of treatment. After the end of treatment, parietal cells are restored after 2-3 days.
Pharmacokinetics
Pharmacokinetics Rabeprazole-health is an algorithm of action of active components after ingestion. Tablets are completely and quickly absorbed from the gastrointestinal tract. Bioavailability is 52% (subject to passage through the liver) and does not increase with repeated use.
Food intake and time of day do not affect absorption. Blood protein binding is 97%. The drug is metabolized in the liver with the active participation of cytochrome P450 enzymes. 90% of the active components are excreted in the urine as metabolites, and the remaining 10% in the feces.
Dosing and administration
The method of administration and dosage depend on the indications for use of the drug, so they should be selected by a doctor for each patient individually. In case of exacerbation of peptic ulcer of the stomach and duodenum, take 20 mg 1-2 times a day. The course of treatment takes 4 weeks, if there is no scarring, then 8 weeks, if the ulcer is localized in the duodenum - 6-12 weeks.
For the treatment of gastroesophageal reflux, 20 mg is prescribed 1-2 times a day for 4-8 weeks. The maintenance dose is 10-20 mg/day of the drug. For Helicobacter pylori infection, the drug is used as part of a triple eradication treatment regimen. Rabeprazole 20 mg is used simultaneously with amoxicillin 1000 mg and clarithromycin 500 mg, the duration of treatment is 7-10 days.
Use Rabeprazole-health during pregnancy
The use of Rabeprazole-Health during pregnancy is not recommended. To date, there is no reliable data on its safety for the human body. Reproductive function studies were conducted on animals, but did not provide evidence of fertility disorders or other side effects for the fetus. However, long-term use of rabeprazole provoked minor placental penetration in rats.
Rabeprazole-health penetrates into breast milk, so it is prohibited to use it during lactation. The drug is not prescribed to minors, since there is not enough information about such therapy.
Contraindications
Rabeprazole-health depends on the body's reaction to the components of the drug. Tablets are not recommended for use in:
- Individual intolerance to rabeprazole and other components of the tablets
- Pregnancy
- Breast-feeding
- Childhood age of the patient
Failure to follow these recommendations may result in serious side effects requiring medical attention.
Side effects Rabeprazole-health
Side effects of Rabeprazole-health occur when the duration of therapy or dosage is exceeded. As a rule, patients complain of abdominal pain, nausea and vomiting, constipation, flatulence. In addition, an increase in the activity of liver transaminases, severe headaches, back and chest pain, dry mouth are possible.
In rare cases, weight gain, stomatitis, increased sweating, cough, bronchitis, swelling, visual and taste disturbances are observed. To eliminate side effects, it is recommended to stop taking Rabeprazole-Health and consult your doctor to adjust the dose.
Overdose
Overdose occurs when the recommended course of treatment is exceeded and high doses of the drug are used. Side effects include headaches and dizziness, nausea, vomiting, abdominal pain, constipation.
Symptomatic supportive therapy is used for treatment. Dialysis is not used, as it is ineffective. In any case, if symptoms of overdose occur, it is necessary to contact the attending physician to adjust the dose of the medication.
Interactions with other drugs
Interaction Rabeprazole-health with other drugs is used with a doctor's permission and in the complex therapy of certain diseases. If the drug is used with ketoconazole, this leads to a decrease in its concentration in the blood plasma and an increase in the level of digoxin. The drug has no clinically significant interactions with drugs that are metabolized in CYP (diazepam, phenytoin, theophylline).
The active substance causes a long-term decrease in the production of hydrochloric acid, so it functions normally with medications whose absorption depends on the pH of the stomach contents. If the drug is used simultaneously with ketoconazole or itraconazole, this leads to a decrease in their concentration in the blood plasma. Therefore, when using these drugs, medical supervision and dosage adjustment are required. Rabeprazole does not interact with antacids such as magnesium or aluminum hydroxide. Low-fat foods do not affect absorption. But when using the drug with fatty foods, absorption is delayed for 4 or more hours, the maximum concentration remains unchanged.
Storage conditions
Storage conditions Rabeprazole-health - tablets should be stored in a dry place, protected from sunlight and out of reach of children. The storage temperature should not exceed 25 °C.
If the above recommendations are not followed, the medication may change its physical and chemical properties, i.e. color, smell, consistency. If this happens, the tablets are prohibited for use and must be disposed of.
Special instructions
Rabeprazole may cause drowsiness, so when using it, it is recommended to avoid working with dangerous machinery or driving a vehicle. Compliance with all recommendations specified in the instructions is a guarantee of maximum therapeutic effect.
Attention!
To simplify the perception of information, this instruction for use of the drug "Rabeprazole-health" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.
Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.